The Cystic Fibrosis Foundation is once again accepting applications for its Impact Grants, a funding initiative that offers…
Articles by Marisa Wexler, MS
Biomx has raised $12 million in financing to advance BX004, a phage therapy being developed to treat bacterial infections…
A European Medicines Agency (EMA) committee recommended that the label for Kaftrio be expanded to cover treatment for people…
Boehringer Ingelheim has launched a Phase 1/2 clinical trial of BI 3720931, an inhaled gene therapy designed to treat…
Young children with cystic fibrosis (CF) have less mature gut bacterial growth over time than do their typically developing…
In cystic fibrosis (CF), certain immune cells show signs of dysfunction very early in life, according to a new…
Registration is now open for BreatheCon 2025, an annual online event hosted by the Cystic Fibrosis Foundation that…
A new triple-combination CFTR modulator therapy — vanzacaftor, tezacaftor, and deutivacaftor — has been approved by the U.S. Food and…
Infection with an airway bacterium called Haemophilus influenzae isn’t linked with worse lung health outcomes among adults with cystic…
A young man with cystic fibrosis (CF) successfully underwent a heart transplant, according to a first-of-its kind report described…